Wealth Architects’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Sell
2,804
-31
-1% -$2.56K 0.02% 219
2025
Q4
$242K Hold
2,835
0.02% 204
2025
Q3
$220K Buy
2,835
+6
+0.2% +$469 0.02% 212
2025
Q2
$221K Sell
2,829
-5
-0.2% -$373 0.02% 206
2025
Q1
$205K Sell
2,834
-40
-1% -$2.86K 0.02% 221
2024
Q4
$213K Buy
+2,874
New +$201K 0.02% 201
2024
Q3
Sell
-2,966
Closed -$274K 215
2024
Q2
$274K Buy
2,966
+9
+0.3% +$797 0.03% 172
2024
Q1
$283K Buy
2,957
+7
+0.2% +$588 0.04% 164
2023
Q4
$225K Buy
+2,950
New +$205K 0.03% 178
2023
Q3
Sell
-3,071
Closed -$290K 192
2023
Q2
$290K Sell
3,071
-71
-2% -$6.17K 0.05% 147
2023
Q1
$260K Buy
3,142
+57
+2% +$4.48K 0.05% 151
2022
Q4
$230K Buy
3,085
+27
+0.9% +$2.08K 0.04% 155
2022
Q3
$253K Sell
3,058
-42
-1% -$4.04K 0.05% 143
2022
Q2
$295K Sell
3,100
-88
-3% -$9.11K 0.06% 140
2022
Q1
$375K Buy
3,188
+40
+1% +$4.49K 0.06% 134
2021
Q4
$408K Sell
3,148
-386
-11% -$45K 0.07% 130
2021
Q3
$400K Buy
3,534
+2
+0.1% +$228 0.08% 118
2021
Q2
$366K Buy
3,532
+236
+7% +$22.2K 0.07% 119
2021
Q1
$276K Buy
3,296
+94
+3% +$7.95K 0.06% 125
2020
Q4
$292K Buy
3,202
+10
+0.3% +$829 0.07% 118
2020
Q3
$255K Sell
3,192
-1
-0% -$78 0.07% 119
2020
Q2
$221K Sell
3,193
-14
-0.4% -$995 0.06% 122
2020
Q1
$202K Sell
3,207
-24
-0.7% -$1.73K 0.07% 118
2019
Q4
$251K Buy
3,231
+9
+0.3% +$703 0.07% 111
2019
Q3
$236K Buy
+3,222
New +$226K 0.07% 113
2019
Q2
Sell
-3,231
Closed -$206K 133
2019
Q1
$206K Buy
+3,231
New +$184K 0.06% 126

Other funds holding EW